{"filing":{"accession_number":"0001279569-26-000593","cik":"0001702123","ticker":"CRDL","company_name":"Cardiol Therapeutics Inc.","form":"6-K","filing_date":"2026-06-25","report_date":null,"primary_document":"cardiol6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1702123/000127956926000593/cardiol6k.htm"},"events":[{"id":13711,"run_id":12179,"accession_number":"0001279569-26-000593","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This exhibit is a news release announcing the results of Cardiol Therapeutics' Annual General Meeting of Shareholders held on June 24, 2026. The disclosure reports shareholder voting outcomes on director elections (eight directors elected with vote percentages ranging from 96.24% to 99.19%) and auditor appointment (BDO Canada LLP). This is a classic shareholder_vote_results disclosure, material because it confirms the composition of the board and auditor for the ensuing fiscal year.","company_name":"Cardiol Therapeutics Inc.","ticker":"CRDL","filing_date":"2026-06-25","form":"6-K","submitted_at":null,"items":[{"id":10931,"accession_number":"0001279569-26-000593","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a news release announcing the results of Cardiol Therapeutics' Annual General Meeting of Shareholders held on June 24, 2026. The disclosure reports shareholder voting outcomes on director elections (eight directors elected with vote percentages ranging from 96.24% to 99.19%) and auditor appointment (BDO Canada LLP). This is a classic shareholder_vote_results disclosure, material because it confirms the composition of the board and auditor for the ensuing fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:46:37.393356+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10931,"accession_number":"0001279569-26-000593","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a news release announcing the results of Cardiol Therapeutics' Annual General Meeting of Shareholders held on June 24, 2026. The disclosure reports shareholder voting outcomes on director elections (eight directors elected with vote percentages ranging from 96.24% to 99.19%) and auditor appointment (BDO Canada LLP). This is a classic shareholder_vote_results disclosure, material because it confirms the composition of the board and auditor for the ensuing fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:46:37.393356+00:00","company_name":"Cardiol Therapeutics Inc.","ticker":"CRDL","filing_date":"2026-06-25"}]}